Lillian L. Siu

2 days ago | ajmc.com | Brooke McCormick |Lillian L. Siu

Ahead of the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago later this week, program chairs Lillian L. Siu, MD, FAACR, incoming AACR president, Princess Margaret Cancer Centre, and Matthew G. Vander Heiden, MD, PhD, director of the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT), shared with The American Journal of Managed Care® what attendees can expect at this year's meeting.

Oct 4, 2024 | onclive.com | Lillian L. Siu

CommentaryVideoOctober 4, 2024Author(s):Lillian L. Siu, MD, FRCPC, discusses the background for evaluating first-line petosemtamab plus pembrolizumab in recurrent/metastatic PD-L1+ HNSCC. Lillian L.

Sep 30, 2024 | onclive.com | Lillian L. Siu

CommentaryVideoSeptember 30, 2024Author(s):Lillian L Siu, MD, FRCPC, discusses a phase 3 trial of petosemtamab plus pembrolizumab vs pembrolizumab alone for recurrent/metastatic PD-L1+ HNSCC.